Literature DB >> 7753138

Anal dynamic graciloplasty in the treatment of intractable fecal incontinence.

C G Baeten1, B P Geerdes, E M Adang, E Heineman, J Konsten, G L Engel, A D Kester, F Spaans, P B Soeters.   

Abstract

BACKGROUND: In patients with intractable fecal incontinence, conventional treatment is not always successful. Dynamic graciloplasty (transposition of the gracilis muscle to the anus with the implantation of stimulating electrodes) was developed to provide such patients with functional neosphincters. We evaluated the clinical results of this new surgical approach and the effects on quality of life.
METHODS: We treated 52 patients with dynamic graciloplasty. The clinical results of treatment were evaluated in an interview, by anal manometry, and by enema testing. The degree of continence was scored. To assess quality of life, four questionnaires were administered (parts 1 and 2 of the Nottingham Health Profile, the State-Trait Anxiety Inventory, and the Self-rating Depression scale).
RESULTS: Among the 52 patients, 38 (73 percent) were continent after a median follow-up of 2.1 years. At 52 weeks the patients' condition had improved with respect to the median frequency of defecation (from five to two times per 24 hours, P < 0.001), the median time defecation could be postponed (from 9 seconds to 19 minutes, P = 0.012), and the median time an enema could be retained (from 0 to 180 seconds, P = 0.005). Patients in whom the technique was successful became less anxious than those in whom it failed (P = 0.002) and improved with regard to effectiveness in their occupations, ability to perform tasks around the home, personal relationships, sexual function, and social life (P = 0.01). They also became less isolated socially (P = 0.05).
CONCLUSIONS: Dynamic graciloplasty is a safe and reliable technique in patients with severe incontinence and may result in a better quality of life.

Entities:  

Mesh:

Year:  1995        PMID: 7753138     DOI: 10.1056/NEJM199506153322403

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  25 in total

1.  [Anal sphincter replacement].

Authors:  C G M I Baeten
Journal:  Chirurg       Date:  2004-01       Impact factor: 0.955

2.  Fecal incontinence: etiology, evaluation, and treatment.

Authors:  Dana M Hayden; Eric G Weiss
Journal:  Clin Colon Rectal Surg       Date:  2011-03

3.  Low-field magnetic resonance imaging of the pelvis in patients with anal dynamic graciloplasty: initial experience.

Authors:  A Cavallaro; F Fellner; K E Matzel; U Stadelmaier; T Rupprecht; B Böwing; W Hohenberger; W Bautz
Journal:  MAGMA       Date:  1998-12       Impact factor: 2.310

Review 4.  [Dynamic graciloplasty vs artificial bowel sphincter in the management of severe fecal incontinence].

Authors:  O Ruthmann; A Fischer; U T Hopt; H J Schrag
Journal:  Chirurg       Date:  2006-10       Impact factor: 0.955

5.  Neurostimulated levator augmentation--a new approach in restoring continence.

Authors:  Christoph Isbert; Nicolas Schlegel; Joachim Reibetanz; Katica Krajinovic; Karsten Schmidt; Christoph-Thomas Germer; Mia Kim
Journal:  Int J Colorectal Dis       Date:  2015-02-10       Impact factor: 2.571

Review 6.  Neosphincter surgery for fecal incontinence: a critical and unbiased review of the relevant literature.

Authors:  Orlin Belyaev; Christophe Müller; Waldemar Uhl
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

7.  Fecal incontinence.

Authors:  Tracy Hull
Journal:  Clin Colon Rectal Surg       Date:  2007-05

8.  Prospective comparison of faecal incontinence grading systems.

Authors:  C J Vaizey; E Carapeti; J A Cahill; M A Kamm
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

Review 9.  Gracilis muscle transposition with electrical stimulation for sphincteric incontinence: a new approach.

Authors:  M B Chancellor; J P Heesakkers; R A Janknegt
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

10.  [Fecal incontinence].

Authors:  J Braun; S Willis
Journal:  Chirurg       Date:  2004-09       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.